| Design, synthesis and molecular modeling of new quinazolin-4 (3H)-one based VEGFR-2 kinase inhibitors for potential anticancer evaluation AE Abdallah, SI Eissa, MMS Al Ward, RR Mabrouk, ABM Mehany, ... Bioorganic chemistry 109, 104695, 2021 | 33 | 2021 |
| Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors AE Abdallah, RR Mabrouk, MMS Al Ward, SI Eissa, EB Elkaeed, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 573-591, 2022 | 30 | 2022 |
| New series of VEGFR-2 inhibitors and apoptosis enhancers: Design, synthesis and biological evaluation AE Abdallah, RR Mabrouk, MR Elnagar, AM Farrag, MH Kalaba, ... Drug Design, Development and Therapy, 587-606, 2023 | 17 | 2023 |
| Design, synthesis, and biological evaluation of new potential unusual modified anticancer immunomodulators for possible non-teratogenic quinazoline-based thalidomide analogs RR Mabrouk, AE Abdallah, HA Mahdy, SA El-Kalyoubi, OJ Kamal, ... International Journal of Molecular Sciences 24 (15), 12416, 2023 | 6 | 2023 |
| REVIEW ON THE SIGNIFICANCE OF QUINAZOLINE DERIVATIVES AS BROAD SPECTRUM ANTI-CANCER AGENTS. M El-Zahabi Al-Azhar Journal of Pharmaceutical Sciences 64 (2), 21-40, 2021 | 3 | 2021 |
Abdallah E. AbdallahLecturer of Medicinal Chemistry, Faculty of Pharmacy, Al-Azhar UniversityVerified email at azhar.edu.eg
